Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-03-10

Clinical Trial Update: Regimen Education and Messaging in Diabetes (REMinD) [NA]

View source ↗

Summary

Clinical trial update on regimen education and messaging for type 2 diabetes focusing on medication adherence; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Northwestern University | Conditions: Diabetes Mellitus, Type 2, Medication Adherence | NA | Status: COMPLETED | Results posted: 2023-03-10